Subclinical Depressive Symptoms and Continued Cannabis Use: Predictors of Negative Outcomes in First Episode Psychosis

• Itxaso González-Ortega ,

  * E-mail: itxaso.gonzalezortega@osakidetza.net

  Affiliation Department of Psychiatry, University Hospital of Alava-Santiago, University of the Basque Country, CIBERSAM, Vitoria, Spain

  ⨯
• Susana Alberich,

  Affiliation Department of Psychiatry, University Hospital of Alava-Santiago, University of the Basque Country, CIBERSAM, Vitoria, Spain

  ⨯
• Enrique Echeburúa,

  Affiliation Department of Psychiatry, University Hospital of Alava-Santiago, University of the Basque Country, CIBERSAM, Vitoria, Spain

  ⨯
• Felipe Aizpuru,

  Affiliation Araba Research Unit, Osakidetza, Vitoria, Spain

  ⨯
• Eduardo Millán,

  Affiliation Dirección de Asistencia Sanitaria, Osakidetza, Vitoria, Spain

  ⨯
• Eduard Vieta,

  Affiliation Bipolar Disorders Program, Institute of Neurosciences, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain

  ⨯
• Carlos Matute,

  Affiliation Achucarro Basque Center for Neuroscience, University of the Basque Country, CIBERNED, Leioa, Spain

  ⨯
• Ana González-Pinto

  Affiliation Department of Psychiatry, University Hospital of Alava-Santiago, University of the Basque Country, CIBERSAM, Vitoria, Spain

  ⨯